for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Neubase Therapeutics Inc

NBSE.O

Latest Trade

8.06USD

Change

0.06(+0.75%)

Volume

170,267

Today's Range

7.73

 - 

8.31

52 Week Range

4.15

 - 

11.78

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest News

BRIEF-Neubase Therapeutics Reports Q2 Loss Per Share Of $0.26

* NEUBASE THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE SECOND FISCAL QUARTER OF 2020

BRIEF-Neubase Therapeutics Announces Proposed Public Offering Of Common Stock

* NEUBASE THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

BRIEF-Neubase Therapeutics Reports Q1 Loss Per Share Of $0.26

* NEUBASE THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE FIRST FISCAL QUARTER OF 2020

BRIEF-NeuBase Therapeutics Receives Notification Of Deficiency From Nasdaq Related To Delayed Quarterly Report On Form 10-Q

* NEUBASE THERAPEUTICS RECEIVES NOTIFICATION OF DEFICIENCY FROM NASDAQ RELATED TO DELAYED QUARTERLY REPORT ON FORM 10-Q

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up